Literature DB >> 16432632

Transmission disequilibrium test provides evidence of association between promoter polymorphisms in 22q11 gene DGCR14 and schizophrenia.

H Wang1, S Duan, J Du, X Li, Y Xu, Z Zhang, Y Wang, G Huang, G Feng, L He.   

Abstract

Recent research has suggested that the DiGeorge syndrome critical region gene 14 (DGCR14) exhibits activity differences of more than 1.5 fold between the haplotypes of the variants in the promoter region. DGCR14 is located at 22q11.21, an acknowledged region for susceptibility to schizophrenia. To test the hypothesis that DGCR14 may be involved in the etiology of the disease, we carried out a family-based association study between the reported functional markers and schizophrenia in 235 Chinese Han trios. We found significant evidence of preferential transmission of the promoter variants of DGCR14 across all the trios (Best p-value = 0.00038, Global p-value = 0.0008). The positive results have suggested that DGCR14 is likely to play an important role in the etiology of schizophrenia in the Chinese Han population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16432632     DOI: 10.1007/s00702-005-0420-3

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  43 in total

Review 1.  Genetic abnormalities of chromosome 22 and the development of psychosis.

Authors:  Nigel M Williams; Michael J Owen
Journal:  Curr Psychiatry Rep       Date:  2004-06       Impact factor: 5.285

2.  Case-control study and transmission disequilibrium test provide consistent evidence for association between schizophrenia and genetic variation in the 22q11 gene ZDHHC8.

Authors:  Wu-Yan Chen; Yong-Yong Shi; Yong-Lan Zheng; Xin-Zhi Zhao; Guang-Ji Zhang; Sheng-Qi Chen; Pei-Di Yang; Lin He
Journal:  Hum Mol Genet       Date:  2004-10-15       Impact factor: 6.150

3.  Further study of a genetic association between the CLDN5 locus and schizophrenia.

Authors:  Lin Ye; Zuyue Sun; Lin Xie; Shuzheng Liu; Guizhi Ju; Jieping Shi; Yaqin Yu; Xuan Zhang; Jun Wei; Qi Xu; Yan Shen
Journal:  Schizophr Res       Date:  2005-06-01       Impact factor: 4.939

4.  MLC1 gene is associated with schizophrenia and bipolar disorder in Southern India.

Authors:  Ranjana Verma; Mitali Mukerji; Deepak Grover; Chandrika B-Rao; Swapan Kumar Das; Shobana Kubendran; Sanjeev Jain; Samir K Brahmachari
Journal:  Biol Psychiatry       Date:  2005-07-01       Impact factor: 13.382

Review 5.  Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: a large-scale association study plus meta-analysis.

Authors:  Jin-Bo Fan; Chang-Shun Zhang; Niu-Fan Gu; Xing-Wang Li; Wei-Wei Sun; Hong-Yan Wang; Guo-Yin Feng; David St Clair; Lin He
Journal:  Biol Psychiatry       Date:  2005-01-15       Impact factor: 13.382

Review 6.  The molecular genetics of the 22q11-associated schizophrenia.

Authors:  Maria Karayiorgou; Joseph A Gogos
Journal:  Brain Res Mol Brain Res       Date:  2004-12-20

Review 7.  Calcium binding protein markers of GABA deficits in schizophrenia--postmortem studies and animal models.

Authors:  Gavin P Reynolds; Zuhal Abdul-Monim; Joanna C Neill; Zhi-Jun Zhang
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

8.  A case-control study provides evidence of association for a functional polymorphism -197C/G in XBP1 to schizophrenia and suggests a sex-dependent effect.

Authors:  Wuyan Chen; Shiwei Duan; Jian Zhou; Yun Sun; Yonglan Zheng; Niufan Gu; Guoyin Feng; Lin He
Journal:  Biochem Biophys Res Commun       Date:  2004-07-02       Impact factor: 3.575

9.  A comprehensive analysis of 22q11 gene expression in the developing and adult brain.

Authors:  T M Maynard; G T Haskell; A Z Peters; L Sikich; J A Lieberman; A-S LaMantia
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-12       Impact factor: 11.205

10.  Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia.

Authors:  Cathryn M Lewis; Douglas F Levinson; Lesley H Wise; Lynn E DeLisi; Richard E Straub; Iiris Hovatta; Nigel M Williams; Sibylle G Schwab; Ann E Pulver; Stephen V Faraone; Linda M Brzustowicz; Charles A Kaufmann; David L Garver; Hugh M D Gurling; Eva Lindholm; Hilary Coon; Hans W Moises; William Byerley; Sarah H Shaw; Andrea Mesen; Robin Sherrington; F Anthony O'Neill; Dermot Walsh; Kenneth S Kendler; Jesper Ekelund; Tiina Paunio; Jouko Lönnqvist; Leena Peltonen; Michael C O'Donovan; Michael J Owen; Dieter B Wildenauer; Wolfgang Maier; Gerald Nestadt; Jean-Louis Blouin; Stylianos E Antonarakis; Bryan J Mowry; Jeremy M Silverman; Raymond R Crowe; C Robert Cloninger; Ming T Tsuang; Dolores Malaspina; Jill M Harkavy-Friedman; Dragan M Svrakic; Anne S Bassett; Jennifer Holcomb; Gursharan Kalsi; Andrew McQuillin; Jon Brynjolfson; Thordur Sigmundsson; Hannes Petursson; Elena Jazin; Tomas Zoëga; Tomas Helgason
Journal:  Am J Hum Genet       Date:  2003-06-11       Impact factor: 11.025

View more
  8 in total

1.  Loss of Goosecoid-like and DiGeorge syndrome critical region 14 in interpeduncular nucleus results in altered regulation of rapid eye movement sleep.

Authors:  Hiromasa Funato; Makito Sato; Christopher M Sinton; Laurent Gautron; S Clay Williams; Amber Skach; Joel K Elmquist; Arthur I Skoultchi; Masashi Yanagisawa
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

Review 2.  Recent progress in the research field of neuropharmacology in China.

Authors:  Jin Li
Journal:  Cell Mol Neurobiol       Date:  2008-02-01       Impact factor: 5.046

Review 3.  Analyses of the associations between the genes of 22q11 deletion syndrome and schizophrenia.

Authors:  Tadao Arinami
Journal:  J Hum Genet       Date:  2006-09-13       Impact factor: 3.172

4.  Supportive evidence for reduced expression of GNB1L in schizophrenia.

Authors:  Hiroki Ishiguro; Minori Koga; Yasue Horiuchi; Emiko Noguchi; Miyuki Morikawa; Yoshimi Suzuki; Makoto Arai; Kazuhiro Niizato; Shyuji Iritani; Masanari Itokawa; Toshiya Inada; Nakao Iwata; Norio Ozaki; Hiroshi Ujike; Hiroshi Kunugi; Tsukasa Sasaki; Makoto Takahashi; Yuichiro Watanabe; Toshiyuki Someya; Akiyoshi Kakita; Hitoshi Takahashi; Hiroyuki Nawa; Tadao Arinami
Journal:  Schizophr Bull       Date:  2008-11-14       Impact factor: 9.306

5.  Analysis of TBX1 variation in patients with psychotic and affective disorders.

Authors:  Birgit H Funke; Todd Lencz; Christine T Finn; Pamela DeRosse; G David Poznik; Alex M Plocik; John Kane; John Rogus; Anil K Malhotra; Raju Kucherlapati
Journal:  Mol Med       Date:  2007 Jul-Aug       Impact factor: 6.354

6.  Systematic analyses of rpm-1 suppressors reveal roles for ESS-2 in mRNA splicing in Caenorhabditis elegans.

Authors:  Kentaro Noma; Alexandr Goncharov; Yishi Jin
Journal:  Genetics       Date:  2014-09-05       Impact factor: 4.562

7.  Spatiotemporal 22q11.21 Protein Network Implicates DGCR8-Dependent MicroRNA Biogenesis as a Risk for Late-Fetal Cortical Development in Psychiatric Diseases.

Authors:  Liang Chen; Wenxiang Cai; Weidi Wang; Zhe Liu; Guan Ning Lin
Journal:  Life (Basel)       Date:  2021-05-31

8.  Rare protein-coding variants implicate genes involved in risk of suicide death.

Authors:  Emily DiBlasi; Andrey A Shabalin; Eric T Monson; Brooks R Keeshin; Amanda V Bakian; Anne V Kirby; Elliott Ferris; Danli Chen; Nancy William; Eoin Gaj; Michael Klein; Leslie Jerominski; W Brandon Callor; Erik Christensen; Ken R Smith; Alison Fraser; Zhe Yu; Douglas Gray; Nicola J Camp; Eli A Stahl; Qingqin S Li; Anna R Docherty; Hilary Coon
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2021-05-27       Impact factor: 3.358

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.